Marcel de Matas
Impact in
- Pharmaceutical Science top 0.2%
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
- Physical and Theoretical Chemistry top 0.5%
- Crystallography and molecular interactions
Papers in
-
- Drug Solubulity and Delivery Systems 23
- Advanced Drug Delivery Systems 5
- Co-authors
- P. YorkN. BlagdenShahzeb KhanZahid HussainPeter YorkMuhammad Usman MinhasMuhammad SohailSyed Ahmed Shah
- Journals
- International Journal of Pharmaceutics (7 papers)European Journal of Pharmaceutical Sciences (6 papers)Journal of Pharmaceutical Sciences (4 papers)Drug Delivery and Translational Research (3 papers)Pharmaceutical Research (2 papers)
- Partner nations
- United KingdomPakistanMalaysia
In The Last Decade
Marcel de Matas
43 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 148
- Pharmaceutical Science 1.1k
- Physical and Theoretical Chemistry 619
- Biomaterials 388
- Rehabilitation 184
- Materials Chemistry 1.1k
Countries citing papers authored by Marcel de Matas
This map shows the geographic impact of Marcel de Matas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcel de Matas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcel de Matas more than expected).
Fields of papers citing papers by Marcel de Matas
This network shows the impact of papers produced by Marcel de Matas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcel de Matas. The network helps show where Marcel de Matas may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Marcel de Matas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 6 | |
| 2 | 2018 | 34 | |
| 3 | 2017 | 28 | |
| 4 | 2016 | 12 | |
| 5 | 2014 | 43 | |
| 6 | Quality by design approach for tablet formulations containing spray coated ramipril by using artificial intelligence techniques | 2012 | 9 |
| 7 | 2012 | 44 | |
| 8 | 2012 | 41 | |
| 9 | 2012 | 61 | |
| 10 | 2011 | 18 | |
| 11 | 2011 | 30 | |
| 12 | 2011 | 18 | |
| 13 | 2010 | 16 | |
| 14 | 2009 | 5 | |
| 15 | 2009 | 3 | |
| 16 | 2009 | 7 | |
| 17 | 2008 | 37 | |
| 18 | 2007 | 26 | |
| 19 | Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates Hit paper breakdown → | 2007 | 1184 |
| 20 | 2007 | 19 |
About Marcel de Matas
Marcel de Matas is a scholar working on Pharmaceutical Science, Molecular Medicine, Analytical Chemistry, Spectroscopy and Computational Mechanics, having authored 43 papers that have together received 3.0k indexed citations. Recurring topics across this work include Drug Solubulity and Delivery Systems (23 papers), Crystallization and Solubility Studies (9 papers), Granular flow and fluidized beds (6 papers), Protein purification and stability (5 papers), Advanced Drug Delivery Systems (5 papers), Inhalation and Respiratory Drug Delivery (5 papers), Analytical Methods in Pharmaceuticals (4 papers) and Analytical Chemistry and Chromatography (3 papers). The work is most often cited by research in Pharmaceutical Science (1.1k citations), Physical and Theoretical Chemistry (619 citations), Biomaterials (388 citations), Rehabilitation (184 citations) and Materials Chemistry (1.1k citations). Marcel de Matas has collaborated with scholars based in United Kingdom, Pakistan and Malaysia. Frequent co-authors include P. York, N. Blagden, Shahzeb Khan, Zahid Hussain, Peter York, Muhammad Usman Minhas, Muhammad Sohail, Syed Ahmed Shah, Mubeen Kousar and Zhenyu Huang. Their work appears in journals such as International Journal of Pharmaceutics, European Journal of Pharmaceutical Sciences, Journal of Pharmaceutical Sciences, Drug Delivery and Translational Research and Pharmaceutical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.